Shares of Eli Lilly LLY and Novo Nordisk NVO were up on Tuesday, likely due to a proposal by President Biden that Medicare ...

Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share ...

Today, Mounjaro and Zepbound both have become blockbusters, and in the most recent quarter, they generated $3.1 billion and ...

Massachusetts Financial Services Co. MA grew its position in Novo Nordisk A/S (NYSE:NVO – Free Report) by 2.8% during the 3rd quarter, according to its most recent filing with the Securities and ...

UBS maintained a Hold rating on Novo Nordisk (LSE: 0QIU). 0QIU market cap is currently DKK3305.4B and has a P/E ratio of 35.08. Based on the recent corporate insider activity of 49 insiders, corporate ...

Amgen's phase 2 data disappointed, but its obesity pipeline still holds potential. See why AMGN stock is appealing even without the full upside from MariTide.

The company reported a Phase 2 study of its injectable MariTide medicine showed an approximately 20% average weight loss over one year for patients who were obese or overweight without diabetes. In ...

Amgen Inc. announced on Tuesday that its experimental weight-loss drug, MariTide, demonstrated an average weight reduction of ...

The Biden administration is proposing a rule that would require Medicare and Medicaid to cover weight-loss drugs, potentially ...

Shares of Danish weight-loss drug maker Novo Nordisk rose 1.3% on Tuesday as U.S. President Joe Biden proposed expanding ...

The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...

The Biden Administration's proposal expands Medicare and Medicaid coverage for anti-obesity drugs, cutting costs for millions ...